Get started
Author

Esther Falcó

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
2017 · J. Grasselli, E. Elez, et al. · Annals of Oncology · 189
PDF
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study
2018 · E. Aranda, P. García-Alfonso, et al. · European Journal of Cancer · 81
Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease
2020 · Jorge Aparicio, Francis Esposito, et al. · Journal of Clinical Medicine · 73
PDF
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial
2021 · Fernando Rivera, Marta Izquierdo-Manuel, et al. · European Journal of Cancer · 70
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial
2019 · C. Santos, D. Azuara, et al. · Annals of Oncology · 29
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy
2019 · Joan Maurel, Vicente Alonso, et al. · JCO Precision Oncology · 27
NEOHX study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER-2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma—18 m DFS analysis.
2015 · Fernando Rivera, Paula Jiménez-Fonseca, et al. · Journal of Clinical Oncology · 27
Antioxidant enzymes change in different non-metastatic stages in tumoral and peritumoral tissues of colorectal cancer
2020 · Auba Gaya-Bover, Reyniel Hernández-López, et al. · The International Journal of Biochemistry & Cell Biology · 26
Phase Ii Study of First-Line Mfolfox Plus Cetuximab (C) for 8 Cycles Followed By Mfolfox Plus C or Single Agent (S/A) C As Maintenance Therapy in Patients (P) with Metastatic Colorectal Cancer (Mcrc): the Macro-2 Trial (Spanish Cooperative Group for the Treatment of Digestive Tumors [Ttd])
2014 · P. García Alfonso, M. Benavides, et al. · Annals of Oncology · 21
The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer
2023 · Ana Fernández Montes, Vicente Alonso Orduña, et al. · The Oncologist · 19
PDF
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study
2021 · J. Sastre, P. García-Alfonso, et al. · ESMO Open · 18
Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
2017 · Antonio Irigoyen, Javier Gallego, et al. · European Journal of Cancer · 18
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
2019 · A. Carrato, M. Benavides, et al. · BMC Cancer · 17
PDF
Mitochondrial Function Differences between Tumor Tissue of Human Metastatic and Premetastatic CRC
2022 · Reyniel Hernández-López, Margalida Torrens-Mas, et al. · Biology · 15
PDF
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma—R0 resection, pCR, and toxicity analysis.
2013 · Fernando Rivera, Paula Jiménez, et al. · Journal of Clinical Oncology · 15
Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer
2023 · I. Vergote, E. Van Nieuwenhuysen, et al. · Gynecologic Oncology · 13
Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)
2018 · Pilar García-Alfonso, Manuel Benavides, et al. · The Oncologist · 12
Incidence of hand–foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen
2012 · Carlos Gómez-Martin, Antonio Sánchez, et al. · Clinical & Translational Oncology · 12
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study
2020 · Ruth Vera, María Luisa Gómez, et al. · Cancers · 11
PDF
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients
2018 · Vicente Alonso, Pilar Escudero, et al. · Neoplasia · 11
PDF
Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol
2010 · Salvador Pita Fernández, Sonia Pértega Díaz, et al. · BMC Cancer · 11
PDF
Non-tumor adjacent tissue of advanced stage from CRC shows activated antioxidant response
2018 · Reyniel Hernández-López, Margalida Torrens-Mas, et al. · Free Radical Biology and Medicine · 10
Phase II Study of Bevacizumab, Capecitabine, and Oxaliplatin Followed by Bevacizumab Plus Erlotinib as First-Line Therapy in Metastatic Colorectal Cancer
2014 · Alberto Muñoz, Carles Pericay, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 10
Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study
2023 · Carles Pericay, Ana Fernández Montes, et al. · Cancers · 8
PDF
Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain
2023 · Rocio Garcia-Carbonero, Beatriz González Astorga, et al. · Clinical & Translational Oncology · 8
PDF
Works count: 54
Citation count: 793
H-index: 15
I10-index: 23
Year
Topic
Type